Xeris Biopharma (XERS) Chief Legal Officer Beth Hecht Sells 16,666 Shares

What Happened Beth Hecht, Chief Legal Officer and Corporate Secretary of Xeris Biopharma (XERS), sold 16,666 shares on August 3, 2026. The reported weighted-average sale price was $8.01 per share for total proceeds of about $133,553. The filing shows the shares were sold in multiple transactions at prices ranging from $7.87 to $8.14.

Key Details

• Transaction type: Sale (code S) — open-market/private sale reported on Form 4.
• Transaction date: August 3, 2026; Form 4 filed August 4, 2026 (appears timely).
• Price: Weighted average $8.01; individual trades ranged $7.87–$8.14. Reporter can provide breakdown on request (per footnote).
• Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted August 8, 2025.
• Shares owned after transaction: Not disclosed in the provided filing.

Context Sales executed under a pre-established 10b5-1 plan are typically scheduled in advance and are intended to insulate the insider from allegations of trading on material nonpublic information. A $133.6K sale is modest in size relative to most company market caps; sales alone do not necessarily signal management’s view of the company's prospects.